Linked Life Data

10532953

Source:http://linkedlifedata.com/resource/pubmed/id/10532953

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10532953rdf:typepubmed:Citationlld:pubmed
pubmed-article:10532953lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C2355627lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0205112lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0070876lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0031640lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0031678lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:10532953lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:10532953pubmed:issue9lld:pubmed
pubmed-article:10532953pubmed:dateCreated1999-11-16lld:pubmed
pubmed-article:10532953pubmed:abstractTextThree weeks after myocardial infarction (MI) in the rat, remodeled hypertrophy of noninfarcted myocardium is at its maximum and the heart is in a compensated stage with no evidence of heart failure. Our hemodynamic measurements at this stage showed a slight but insignificant decrease of +dP/dt but a significantly higher left ventricular end-diastolic pressure. To investigate the basis of the diastolic dysfunction, we explored possible defects in the beta-adrenergic receptor-G(s/i) protein-adenylyl cyclase-cAMP-protein kinase A-phosphatase pathway, as well as molecular or functional alterations of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban (PLB). We found no significant difference in both mRNA and protein levels of sarcoplasmic reticulum Ca(2+)-ATPase and PLB in post-MI left ventricle compared with control. However, the basal levels of both the protein kinase A-phosphorylated site (Ser16) of PLB (p16-PLB) and the calcium/calmodulin-dependent protein kinase-phosphorylated site (Thr17) of PLB (p17-PLB) were decreased by 76% and 51% in post-MI myocytes (P<0.05), respectively. No change was found in the beta-adrenoceptor density, G(salpha) protein level, or adenylyl cyclase activity. Inhibition of phosphodiesterase and G(i) protein by Ro-20-1724 and pertussis toxin, respectively, did not correct the decreased p16-PLB or p17-PLB levels. Stimulation of beta-adrenoceptor or adenylyl cyclase increased both p16-PLB and p17-PLB in post-MI myocytes to the same levels as in sham myocytes, suggesting that decreased p16-PLB and p17-PLB in post-MI myocytes is not due to a decrease in the generation of p16-PLB or p17-PLB. We found that type 1 phosphatase activity was increased by 32% (P<0.05) with no change in phosphatase 2A activity. Okadaic acid, a protein phosphatase inhibitor, significantly increased p16-PLB and p17-PLB levels in post-MI myocytes and partially corrected the prolonged relaxation of the [Ca(2+)](i) transient. In summary, prolonged relaxation of post-MI remodeled myocardium could be explained, in part, by altered basal levels of p16-PLB and p17-PLB caused by increased protein phosphatase 1 activity.lld:pubmed
pubmed-article:10532953pubmed:languageenglld:pubmed
pubmed-article:10532953pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:citationSubsetIMlld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10532953pubmed:statusMEDLINElld:pubmed
pubmed-article:10532953pubmed:monthOctlld:pubmed
pubmed-article:10532953pubmed:issn1524-4571lld:pubmed
pubmed-article:10532953pubmed:authorpubmed-author:WangSSlld:pubmed
pubmed-article:10532953pubmed:authorpubmed-author:El-SherifNNlld:pubmed
pubmed-article:10532953pubmed:authorpubmed-author:HuangBBlld:pubmed
pubmed-article:10532953pubmed:authorpubmed-author:BoutjdirMMlld:pubmed
pubmed-article:10532953pubmed:authorpubmed-author:QinDDlld:pubmed
pubmed-article:10532953pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10532953pubmed:day29lld:pubmed
pubmed-article:10532953pubmed:volume85lld:pubmed
pubmed-article:10532953pubmed:ownerNLMlld:pubmed
pubmed-article:10532953pubmed:authorsCompleteYlld:pubmed
pubmed-article:10532953pubmed:pagination848-55lld:pubmed
pubmed-article:10532953pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:meshHeadingpubmed-meshheading:10532953...lld:pubmed
pubmed-article:10532953pubmed:year1999lld:pubmed
pubmed-article:10532953pubmed:articleTitleDiminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases.lld:pubmed
pubmed-article:10532953pubmed:affiliationCardiology Division, Department of Medicine, State University of New York Health Science Center and Veterans Affairs Medical Center, Brooklyn, NY 11203, USA.lld:pubmed
pubmed-article:10532953pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10532953pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10532953lld:pubmed